Enveric Biosciences, Inc. (ENVB) › Shareholders' EquityEnveric Biosciences, Inc. (ENVB) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: -$10.1K2010: -$49.5K2011: $4.6K2012: -$20.1K2013: -$20.2K2014: -$3.9K2015: $258.5K2016: $11.66M2017: $19.45M2018: -$65.5K2019: -$1.81M2020: $3.42M2021: $22.31M2022: $14.67M2023: $1.96M2024: $1.59M2025: $4.18M$4.18M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$4.18M+162.3%2024$1.59M-18.6%2023$1.96M-86.7%2022$14.67M-34.2%2021$22.31M+553.1%2020$3.42M+288.5%2019-$1.81M-2667.7%2018-$65.5K-100.3%2017$19.45M+66.7%2016$11.66M+4411.5%2015$258.5K+6778.7%2014-$3.9K+80.9%2013-$20.2K-0.8%2012-$20.1K-540.5%2011$4.6K+109.2%2010-$49.5K-391.5%2009-$10.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share